Antimicrobial susceptibility and biofilm formation of Staphylococcus epidermidis small colony variants associated with prosthetic joint infection

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 3, 2012, Pages 224-229

  Maduka Ezeh, Awele N ^a   Greenwood Quaintance, Kerryl E ^a   Karau, Melissa J ^a   Berbari, Elie F ^a   Osmon, Douglas R ^a   Hanssen, Arlen D ^a   Steckelberg, James M ^a   Patel, Robin ^a  

^a MAYO CLINIC   (United States)

Author keywords

Small colony variant; Staphylococcus epidermidis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFOXITIN; COTRIMOXAZOLE; GENTAMICIN; HEMIN; KANAMYCIN; MENADIONE; OXACILLIN; THYMIDINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUXOTROPHY; BACTERIUM ISOLATION; BIOFILM; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTHESIS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BIOFILMS; HUMANS; MICROBIAL SENSITIVITY TESTS; OSTEOARTHRITIS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84867635443     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.06.029     Document Type: Article

References (42)

1. Alatoom A.A., Cunningham S.A., Ihde S.M., Mandrekar J., Patel R. Comparison of direct colony method versus extraction method for identification of Gram-positive cocci by use of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2011, 49:2868-2873.
2. Baumert N., von Eiff C., Schaaff F., Peters G., Proctor R.A., Sahl H.G. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist 2002, 8:253-260.
3. Bayston R., Ashraf W., Smith T. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother 2007, 59:848-853.
4. Besier S., Zander J., Kahl B.C., Kraiczy P., Brade V., Wichelhaus T.A. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother 2008, 52:2183-2189.
5. Bozic K.J., Ries M.D. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005, 87:1746-1751.
6. Brouillette E., Martinez A., Boyll B.J., Allen N.E., Malouin F. Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol Med Microbiol 2004, 41:35-41.
7. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - ninth edition, M07-A9 2012, CLSI, Wayne, PA.
8. Darouiche R.O., Hamill R.J. Antibiotic penetration of and bactericidal activity within endothelial cells. Antimicrob Agents Chemother 1994, 38:1059-1064.
9. Deighton M., Borland R. Regulation of slime production in Staphylococcus epidermidis by iron limitation. Infect Immun 1993, 61:4473-4479.
10. Del Pozo J.L., Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med 2009, 361:787-794.
11. Ender M., McCallum N., Berger-Bachi B. Impact of mecA promoter mutations on mecA expression and beta-lactam resistance levels. Int J Med Microbiol 2008, 298:607-617.
12. Frank K.L., Reichert E.J., Piper K.E., Patel R. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother 2007, 51:888-895.
13. Geipel U. Pathogenic organisms in hip joint infections. Int J Med Sci 2009, 6:234-240.
14. Hososaka Y., Hanaki H., Endo H., Suzuki Y., Nagasawa Z., Otsuka Y., et al. Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA. J Infect Chemother 2007, 13:79-86.
15. Kohner P., Uhl J., Kolbert C., Persing D., Cockerill F. Comparison of susceptibility testing methods with mecA gene analysis for determining oxacillin (methicillin) resistance in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus spp. J Clin Microbiol 1999, 37:2952-2961.
16. Kristich C.J., Li Y.H., Cvitkovitch D.G., Dunny G.M. Esp-independent biofilm formation by Enterococcus faecalis. J Bacteriol 2004, 186:154-163.
17. Kurtz S.M., Lau E., Schmier J., Ong K.L., Zhao K., Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008, 23:984-991.
18. Labbe A.C., Demers A.M., Rodrigues R., Arlet V., Tanguay K., Moore D.L. Surgical-site infection following spinal fusion: a case-control study in a children's hospital. Infect Control Hosp Epidemiol 2003, 24:591-595.
19. Lannergard J., von Eiff C., Sander G., Cordes T., Seggewiss J., Peters G., et al. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2008, 52:4017-4022.
20. Maduka-Ezeh A., Seville M.T., Kusne S., Vikram H.R., Blair J.E., Greenwood-Quaintance K., et al. Thymidine auxotrophic Staphylococcus aureus small colony variant endocarditis and left ventricular assist device infection. J Clin Microbiol 2012, 50:1102-1105.
21. McNamara P.J., Proctor R.A. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents 2000, 14:117-122.
22. Mok J.M., Guillaume T.J., Talu U., Berven S.H., Deviren V., Kroeber M., et al. Clinical outcome of deep wound infection after instrumented posterior spinal fusion: a matched cohort analysis. Spine (Phila Pa 1976) 2009, 34:578-583.
23. Norstrom T., Lannergard J., Hughes D. Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus. Antimicrob Agents Chemother 2007, 51:4438-4446.
24. Piper K.E., Jacobson M.J., Cofield R.H., Sperling J.W., Sanchez-Sotelo J., Osmon D.R., et al. Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol 2009, 47:1878-1884.
25. Pourmand M.R., Abdossamadi Z., Salari M.H., Hosseini M. Slime layer formation and the prevalence of mecA and aap genes in Staphylococcus epidermidis isolates. J Infect Dev Ctries 2011, 5:34-40.
26. Proctor R.A., Peters G. Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin Infect Dis 1998, 27:419-422.
27. Proctor R.A., van Langevelde P., Kristjansson M., Maslow J.N., Arbeit R.D. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995, 20:95-102.
28. Proctor R.A., von Eiff C., Kahl B.C., Becker K., McNamara P., Herrmann M., et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006, 4:295-305.
29. Sculco T.P. The economic impact of infected joint arthroplasty. Orthopedics 1995, 18:871-873.
30. Sendi P., Rohrbach M., Graber P., Frei R., Ochsner P.E., Zimmerli W. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 2006, 43:961-967.
31. Singh R., Ray P., Das A., Sharma M. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J Med Microbiol 2009, 58:1067-1073.
32. Singh R., Ray P., Das A., Sharma M. Enhanced production of exopolysaccharide matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony variant. J Med Microbiol 2010, 59:521-527.
33. Stepanović S., Vukovic D., Hola V., Di Bonaventura G., Djukic S., Cirkovic I., et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. Apmis 2007, 115:891-899.
34. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
35. Trampuz A., Piper K.E., Jacobson M.J., Hanssen A.D., Unni K.K., Osmon D.R., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007, 357:654-663.
36. von Eiff C. Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians. Int J Antimicrob Agents 2008, 31:507-510.
37. von Eiff C., Heilmann C., Proctor R.A., Woltz C., Peters G., Gotz F. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 1997, 179:4706-4712.
38. von Eiff C., McNamara P., Becker K., Bates D., Lei X.H., Ziman M., et al. Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol 2006, 188:687-693.
39. von Eiff C., Proctor R.A., Peters G. Staphylococcus aureus small colony variants: formation and clinical impact. Int J Clin Pract Supp 2000, 44-49.
40. Wellinghausen N., Chatterjee I., Berger A., Niederfuehr A., Proctor R.A., Kahl B.C. Characterization of clinical Enterococcus faecalis small-colony variants. J Clin Microbiol 2009, 47(9):2802-2811.
41. Wu M., von Eiff C., Al Laham N., Tsuji B.T. Vancomycin and daptomycin pharmacodynamics differ against a site-directed Staphylococcus epidermidis mutant displaying the small-colony-variant phenotype. Antimicrob Agents Chemother 2009, 53:3992-3995.
42. Zander J., Besier S., Saum S.H., Dehghani F., Loitsch S., Brade V., et al. Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. Infect Immun 2008, 76:1333-1339.